Cochrane · systematic review · CD009509

Multidisciplinary rehabilitation after primary brain tumour treatment

Khan, F, Amatya, B, Ng, L, et al. · Cochrane Database of Systematic Reviews · 2015 · Cochrane Library

SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
13
current version
GRADE rated
10
No studies
1
Included studies
NR
No studies 1 · 7.7%Ungraded 2 · 15.4%Very low 0 · 0%Low 10 · 76.9%Moderate 0 · 0%High 0 · 0%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

Questions and results

Comparison

Population: 106 participants with primary brain tumour
13 questions
OutcomeEffectEvidenceStatus / GRADE
Change in short‐term disability (function) FIM motor
no estimate extracted1 study · 106 participantsLow
Change in short‐term disability (cognition) FIM cognition
no estimate extracted1 study · 106 participantsLow
Change in long‐term disability (function) FIM motor
no estimate extracted1 study · 106 participantsLow
Change in long‐term disability (cognition) FIM cognition
no estimate extracted1 study · 106 participantsLow
Change in short‐term psychological outcomes DASS (total)
no estimate extracted1 study · 106 participantsLow
Change in short‐term participation PIPP (total)
no estimate extracted1 study · 106 participantsLow
Change in short‐term QoL CARES‐SF (global)
no estimate extracted1 study · 106 participantsLow
Change in long‐term psychological outcomes DASS (total)
no estimate extracted1 study · 106 participantsLow
Change in long‐term participation PIPP (total)
no estimate extracted1 study · 106 participantsLow
Change in long‐term QoL CARES‐SF (global)
no estimate extracted1 study · 106 participantsLow
Change in other outcomes
no estimate extractedNRNo studies
Cost‐ effectiveness
no estimate extracted1 study · 106 participantsUngraded
Serious adverse events
no estimate extracted1 study · 106 participantsUngraded